Stock Details
BHC is Bausch Health Companies Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 12.95$. Average daily volumn in 3 months 7.15M. Market cap 3.16B



Stock symbol : BHC. Exchange : NYSE. Currency : USD
Lastest price : 8.75$. Total volume : 16.70M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Bausch Health Companies Inc. (BHC)
Last Price
8.75$
Change
1.48
Volume
16.70M

Previous Close7.27
Open7.69
Day Range7.50-8.76
Bid8.71 x 3.2k
Ask8.72 x 4k
Volume16.7M
Average Volume7.15M
Market Cap3.16B
Beta1.66
52 Week Range6.88-30.30
Trailing P/EN/A
Foward P/E1.47
Dividend (Yield %)N/A
Ex-Dividend Date2010-11-10



Financial Details


According to Bausch Health Companies Inc.'s financial reports the company's revenue in 2021 were 8.43B an increase(0%) over the years 2020 revenue that were of 8.03B. In 2021 the company's total earnings were -948M while total earnings in 2020 were -560M( +69.29%).


Loading ...



Organization

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical... , and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Market Cap:
3.16B
Revenue:
8.43B
Total Assets:
29.2B
Total Cash:
582M


News about "Bausch Health Companies Inc."

bausch-health-announces-2022-annual-meeting-of-shareholder-results-updates-to-its-board-of-directors-image

Bausch Health Announces 2022 Annual Meeting of Shareholder Results, Updates to its Board of Directors

Source from : Business Insider - 2 days ago

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced the results of its 2022 annual meeting of shareholders and certain other updates with respect to the ...See details»


Bausch Health Companies Inc.: End of an Era as Papa Leaves Bausch's Board; Shares Still Trade Below FVE After 18% Gain

Source from : YAHOO!Finance - 1 days ago

Find the latest Bausch Health Companies Inc. (BHC) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance ...See details»


Why Bausch Health Stock Is Bolting Higher Today

Source from : Nasdaq - 1 days ago

Shares of the specialty pharmaceutical company Bausch Health Companies are surging today in response to the news that Joseph Papa has resigned from the board of dir ...See details»


Bausch Health Companies (NYSE:BHC) Reaches New 52-Week Low at $7.02

Source from : Defense World - 1 days ago

Bausch Health Companies Inc. (NYSE:BHC โ€“ Get Rating) shares hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $7.02 and last traded at $7.19, with a volume of ...See details»


bausch-health-names-hedge-fund-manager-john-paulson-as-chairperson-image

Bausch Health names hedge fund manager John Paulson as chairperson

Source from : Times Colonist - 1 days ago

Bausch Health Companies Inc. says hedge fund manager John Paulson has been named chairperson of its board of directors, replacing Joseph Papa. Paulson is president and portfolio manager of Paulson & ...See details»


right-now-may-be-the-best-buy-in-window-for-bausch-health-companies-inc-bhc-image

Right Now May Be the Best Buy-In Window for Bausch Health Companies Inc. (BHC)

Source from : investchronicle - 3 days ago

Bausch Health Companies Inc. (BHC) is priced at $7.30 after the most recent trading session. At the very opening of the session, the stock price was $7.46 and reached a high price of $7.60, prior to ...See details»


bausch-health-companies-inc-nysebhc-expected-to-announce-earnings-of-091-per-share-image

Bausch Health Companies Inc. (NYSE:BHC) Expected to Announce Earnings of $0.91 Per Share

Source from : Defense World - 15 days ago

Analysts expect Bausch Health Companies Inc. (NYSE:BHC โ€“ Get Rating) to post $0.91 earnings per share (EPS) for the current quarter, Zacks reports. Four analysts have issued estimates for Bausch ...See details»


Bausch Health Companies Inc. (BHC) is on the roll with an average volume of 6.70M in the recent 3 months

Source from : investchronicle - 12 days ago

Bausch Health Companies Inc. (BHC) is priced at $7.31 after the most recent trading session. At the very opening of the session, the stock price was $7.86 and reached a high price of $7.93, prior to ...See details»


(PR) Bausch Health Issues Form 8-K for 2022 Annual Meeting of Shareholders Presentation

Source from : Barron's - 4 days ago

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced the Company is providing a presentation on its business during the Company's Annual Meeting of ...See details»


What Are The Analystsโ€™ Predictions For Bausch Health Companies Inc. (NYSE: BHC)?

Source from : stocksregister - 12 days ago

Bausch Health Companies Inc. (NYSE:BHC) price is hovering lower on Monday, June 13, dropping -6.10% below its previous close. >> 5 Best Growth Stocks for 2022 << >> 5 Best Growth Stocks for 2022 << A ...See details»


Bausch Health Companies Inc. (NYSE:BHC) Receives Consensus Recommendation of โ€œBuyโ€ from Analysts

Source from : ETF Daily News - 17 days ago

Shares of Bausch Health Companies Inc. (NYSE:BHC โ€“ Get Rating) have received a consensus rating of โ€œBuyโ€ from the ten brokerages that are presently covering the stock, Marketbeat.com reports.See details»


UPDATE 2-Bausch Health suspends plans for Solta IPO

Source from : Reuters - 9 days ago

Bausch Health Companies Inc said on Thursday it was suspending plans for the initial public offering of its unit Solta Medical due to challenging market conditions.See details»


Bausch Health halts IPO plan for skin-care division, citing โ€˜challenging market conditionsโ€™

Source from : MarketWatch on MSN.com - 8 days ago

Bausch Health Cos. Inc. halts plans to proceed with the initial public offering of its skin-care business, citing "challenging market conditions." ...See details»


Bausch Health Companies Inc. (NYSE:BHC) Sees Significant Growth in Short Interest

Source from : ETF Daily News - 24 days ago

Bausch Health Companies Inc. (NYSE:BHC โ€“ Get Rating) saw a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 18,090,000 shares, an increase ...See details»